https://algipharma.com/wp-content/uploads/2016/03/algipharma-logo-skisse-340x156.png 0 0 Philip Rye https://algipharma.com/wp-content/uploads/2016/03/algipharma-logo-skisse-340x156.png Philip Rye2016-03-09 12:43:002016-05-25 09:01:10AlgiPharma signs new license agreement with NTNU
AlgiPharma signs new license agreement with NTNU
AlgiPharma signed a new license agreement securing exclusive the global rights for the OligoG patent portfolio from the Norwegian University of Science and Technology (NTNU) for all disease areas and medical applications, except non-inhalation treatment in oncology.
Yngvar P. Berg, CEO; firstname.lastname@example.org
March 9, 2016